Seattle Genetics (SGEN)

55.74 +0.31 (0.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/26/18 *Est.)
- M&A (3/31/18 *Est)

Latest Headlines

Form 4 SEATTLE GENETICS INC For: May 18 Filed by: AKKARAJU SRINIVAS May 22, 2018 8:17 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 18 Filed by: WELCH DANIEL G May 22, 2018 8:14 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 18 Filed by: Simonian Nancy A May 22, 2018 8:11 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 18 Filed by: Orwin John A May 22, 2018 8:10 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 18 Filed by: LIPPMAN MARC E May 22, 2018 8:08 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 18 Filed by: GRYSKA DAVID W May 22, 2018 8:07 PM - SEC Filing Form 8-K/A SEATTLE GENETICS INC For: Mar 09 May 21, 2018 4:37 PM - SEC Filing Form 8-K SEATTLE GENETICS INC For: May 17 May 18, 2018 5:17 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 18 Filed by: 667, L.P. May 18, 2018 4:26 PM - SEC Filing Seattle Genetics Appoints Roger D. Dansey, M.D., Chief Medical Officer May 17, 2018 9:00 AM - BizWire Seattle Genetics (SGEN) Announces Data Presentations at ASCO May 17, 2018 8:05 AM - StreetInsider Seattle Genetics Announces Data Presentations at 2018 ASCO Annual Meeting May 17, 2018 8:00 AM - BizWire Form CT ORDER SEATTLE GENETICS INC May 14, 2018 11:55 AM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 09 Filed by: SIEGALL CLAY B May 11, 2018 8:03 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 09 Filed by: Cline Darren S May 11, 2018 8:03 PM - SEC Filing Form 4 BAKER FELIX For: May 04 Filed by: SEATTLE GENETICS INC /WA May 8, 2018 5:28 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: May 03 Filed by: Cline Darren S May 7, 2018 7:09 PM - SEC Filing Form 4 BAKER FELIX For: Apr 30 Filed by: SEATTLE GENETICS INC /WA May 2, 2018 6:06 PM - SEC Filing Form SC 13D/A SEATTLE GENETICS INC Filed by: BAKER BROS. ADVISORS LP May 2, 2018 5:30 PM - SEC Filing Seattle Genetics to Present at the Bank of America Merrill Lynch Health Care Conference 2018 May 2, 2018 8:00 AM - BizWire Form 10-Q SEATTLE GENETICS INC For: Mar 31 April 26, 2018 5:40 PM - SEC Filing Form 8-K SEATTLE GENETICS INC For: Apr 26 April 26, 2018 4:25 PM - SEC Filing Seattle Genetics (SGEN) Reports Q1 Loss of $0.73 April 26, 2018 4:05 PM - StreetInsider Seattle Genetics Reports First Quarter 2018 Financial Results April 26, 2018 4:02 PM - BizWire Form CT ORDER SEATTLE GENETICS INC April 20, 2018 9:33 AM - SEC Filing Form CT ORDER SEATTLE GENETICS INC April 16, 2018 10:43 AM - SEC Filing Form 10-Q/A SEATTLE GENETICS INC For: Sep 30 April 13, 2018 5:02 PM - SEC Filing Seattle Genetics (SGEN) Announces Pre-Clinical & Clinical Data with ADCETRIS (brentuximab vedotin), ladiratuzumab vedotin, SGN-CD48A and SGN-2FF April 12, 2018 8:09 AM - StreetInsider Seattle Genetics Highlights Novel Antibody-Drug Conjugate Technologies and Immuno-Oncology Program Advances at the American Association for Cancer Research (AACR) Annual Meeting April 12, 2018 8:00 AM - BizWire Form 4 SEATTLE GENETICS INC For: Apr 09 Filed by: SIEGALL CLAY B April 11, 2018 8:38 PM - SEC Filing Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter Financial Results on April 26, 2018 April 5, 2018 8:00 AM - BizWire Form DEF 14A SEATTLE GENETICS INC For: May 18 April 4, 2018 6:06 AM - SEC Filing Form DEFA14A SEATTLE GENETICS INC April 4, 2018 6:06 AM - SEC Filing Seattle Genetics (SGEN) & Astella Pharma Granted FDA Breakthrough Therapy Designation for Enfortumab Vedotin March 26, 2018 8:02 AM - StreetInsider Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer March 26, 2018 8:00 AM - PR NewsWire Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer March 26, 2018 8:00 AM - BizWire Form 4 SEATTLE GENETICS INC For: Mar 20 Filed by: DRACHMAN JONATHAN G March 22, 2018 9:37 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 20 Filed by: Cline Darren S March 22, 2018 9:37 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 20 Filed by: LIU JEAN I March 22, 2018 9:35 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 20 Filed by: SIMPSON TODD E March 22, 2018 9:33 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 20 Filed by: SIEGALL CLAY B March 22, 2018 9:33 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 20 Filed by: HIMES VAUGHN B March 22, 2018 9:31 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 20 Filed by: DRACHMAN JONATHAN G March 22, 2018 7:04 PM - SEC Filing Seattle Genetics (SGEN) PT Raised to $73 at RBC Capital March 21, 2018 7:54 AM - StreetInsider Seattle Genetics (SGEN) PT Lowered to $67 at Morgan Stanley March 21, 2018 7:36 AM - StreetInsider Seattle Genetics (SGEN) PT Lowered to $62 at BofA/Merrill Lynch March 21, 2018 7:02 AM - StreetInsider Form 8-K SEATTLE GENETICS INC For: Mar 20 March 20, 2018 5:24 PM - SEC Filing Seattle Genetics (SGEN) Announces FDA Approval of ADCETRIS in Combination with Chemotherapy for Adults with Previously Untreated Stage III or IV Classical Hodgkin Lymphoma March 20, 2018 12:50 PM - StreetInsider Seattle Genetics Announces FDA Approval of ADCETRIS® (Brentuximab Vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Stage III or IV Classical Hodgkin Lymphoma March 20, 2018 12:48 PM - BizWire Barclays Reinstate Seattle Genetics (SGEN) at Overweight March 20, 2018 4:50 AM - StreetInsider Form 4 SEATTLE GENETICS INC For: Mar 15 Filed by: HIMES VAUGHN B March 19, 2018 7:35 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 15 Filed by: Seth Alpna March 15, 2018 9:35 PM - SEC Filing Form 3 SEATTLE GENETICS INC For: Mar 15 Filed by: Seth Alpna March 15, 2018 9:35 PM - SEC Filing Form 8-K SEATTLE GENETICS INC For: Mar 14 March 15, 2018 8:16 AM - SEC Filing Seattle Genetics (SGEN) Names Dr. Alpna Seth to Board March 15, 2018 8:04 AM - StreetInsider Seattle Genetics Appoints Dr. Alpna Seth to Board of Directors March 15, 2018 8:00 AM - BizWire Form 4 SEATTLE GENETICS INC For: Mar 09 Filed by: SIEGALL CLAY B March 13, 2018 8:44 PM - SEC Filing Seattle Genetics to Present at the Barclays Global Healthcare Conference 2018 March 13, 2018 8:00 AM - BizWire Form 8-K SEATTLE GENETICS INC For: Mar 09 March 9, 2018 5:02 PM - SEC Filing Seattle Genetics (SGEN) Completes Acquisition of Cascadian Therapeutics (CASC) March 9, 2018 9:28 AM - StreetInsider Seattle Genetics Completes Acquisition of Cascadian Therapeutics March 9, 2018 9:26 AM - BizWire Seattle Genetics Completes Tender Offer for All Shares of Cascadian Therapeutics March 9, 2018 6:00 AM - BizWire Form SC 13G/A SEATTLE GENETICS INC Filed by: BlackRock Inc. March 8, 2018 3:53 PM - SEC Filing Form 4 SEATTLE GENETICS INC For: Mar 05 Filed by: DRACHMAN JONATHAN G March 7, 2018 8:27 PM - SEC Filing Seattle Genetics (SGEN) Initiates New Phase 1 Study in R/R Multiple Myeloma March 7, 2018 8:03 AM - StreetInsider Seattle Genetics Initiates New Phase 1 Study in Relapsed or Refractory Multiple Myeloma March 7, 2018 8:00 AM - BizWire Seattle Genetics to Present at Cowen and Company 38th Annual Health Care Conference February 27, 2018 8:00 AM - BizWire Form SC 13G/A SEATTLE GENETICS INC Filed by: PRIMECAP MANAGEMENT CO/CA/ February 27, 2018 6:28 AM - SEC Filing Form CT ORDER SEATTLE GENETICS INC February 26, 2018 11:40 AM - SEC Filing Full Article List